Report copyright - Clinical experience with infliximab biosimilar...PPS 0 20 40 60 80 100 % o n s t u d y d r u g CT-P13 206 205 203 203 203 202 112 IN X 202 202 201 199 198 196 105 No. at risk 0 8 16
Please pass captcha verification before submit form